John A. Zuris, Ph.D. - Publications

Affiliations: 
2012 Chemistry University of California, San Diego, La Jolla, CA 
Area:
protein structure, dynamics and folding; 2, 3 and 4D NMR spectroscopy; PCR; equilibrium and kinetic-fluorescence, absorbance and circular dichroism spectroscopies

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wang M, Zuris JA, Meng F, Rees H, Sun S, Deng P, Han Y, Gao X, Pouli D, Wu Q, Georgakoudi I, Liu DR, Xu Q. Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles. Proceedings of the National Academy of Sciences of the United States of America. PMID 26929348 DOI: 10.1073/pnas.1520244113  0.44
2015 Hubbard BP, Badran AH, Zuris JA, Guilinger JP, Davis KM, Chen L, Tsai SQ, Sander JD, Joung JK, Liu DR. Continuous directed evolution of DNA-binding proteins to improve TALEN specificity. Nature Methods. 12: 939-42. PMID 26258293 DOI: 10.1038/nmeth.3515  0.44
2015 Davis KM, Pattanayak V, Thompson DB, Zuris JA, Liu DR. Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nature Chemical Biology. 11: 316-8. PMID 25848930 DOI: 10.1038/nchembio.1793  0.44
2014 Tamir S, Rotem-Bamberger S, Katz C, Morcos F, Hailey KL, Zuris JA, Wang C, Conlan AR, Lipper CH, Paddock ML, Mittler R, Onuchic JN, Jennings PA, Friedler A, Nechushtai R. Integrated strategy reveals the protein interface between cancer targets Bcl-2 and NAF-1. Proceedings of the National Academy of Sciences of the United States of America. 111: 5177-82. PMID 24706857 DOI: 10.1073/pnas.1403770111  0.44
2013 Tamir S, Zuris JA, Agranat L, Lipper CH, Conlan AR, Michaeli D, Harir Y, Paddock ML, Mittler R, Cabantchik ZI, Jennings PA, Nechushtai R. Nutrient-deprivation autophagy factor-1 (NAF-1): biochemical properties of a novel cellular target for anti-diabetic drugs. Plos One. 8: e61202. PMID 23717386 DOI: 10.1371/journal.pone.0061202  0.44
2013 Baxter EL, Zuris JA, Wang C, Vo PL, Axelrod HL, Cohen AE, Paddock ML, Nechushtai R, Onuchic JN, Jennings PA. Allosteric control in a metalloprotein dramatically alters function. Proceedings of the National Academy of Sciences of the United States of America. 110: 948-53. PMID 23271805 DOI: 10.1073/pnas.1208286110  0.44
2012 Nechushtai R, Conlan AR, Harir Y, Song L, Yogev O, Eisenberg-Domovich Y, Livnah O, Michaeli D, Rosen R, Ma V, Luo Y, Zuris JA, Paddock ML, Cabantchik ZI, Jennings PA, et al. Characterization of Arabidopsis NEET reveals an ancient role for NEET proteins in iron metabolism. The Plant Cell. 24: 2139-54. PMID 22562611 DOI: 10.1105/tpc.112.097634  0.44
2012 Zuris JA, Ali SS, Yeh H, Nguyen TA, Nechushtai R, Paddock ML, Jennings PA. NADPH inhibits [2Fe-2S] cluster protein transfer from diabetes drug target MitoNEET to an apo-acceptor protein. The Journal of Biological Chemistry. 287: 11649-55. PMID 22351774 DOI: 10.1074/jbc.M111.319731  0.44
2011 Zuris JA, Harir Y, Conlan AR, Shvartsman M, Michaeli D, Tamir S, Paddock ML, Onuchic JN, Mittler R, Cabantchik ZI, Jennings PA, Nechushtai R. Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein. Proceedings of the National Academy of Sciences of the United States of America. 108: 13047-52. PMID 21788481 DOI: 10.1073/pnas.1109986108  0.44
2011 Conlan AR, Paddock ML, Homer C, Axelrod HL, Cohen AE, Abresch EC, Zuris JA, Nechushtai R, Jennings PA. Mutation of the His ligand in mitoNEET stabilizes the 2Fe-2S cluster despite conformational heterogeneity in the ligand environment. Acta Crystallographica. Section D, Biological Crystallography. 67: 516-23. PMID 21636891 DOI: 10.1107/S0907444911011577  0.44
2011 Nechushtai R, Lammert H, Michaeli D, Eisenberg-Domovich Y, Zuris JA, Luca MA, Capraro DT, Fish A, Shimshon O, Roy M, Schug A, Whitford PC, Livnah O, Onuchic JN, Jennings PA. Allostery in the ferredoxin protein motif does not involve a conformational switch. Proceedings of the National Academy of Sciences of the United States of America. 108: 2240-5. PMID 21266547 DOI: 10.1073/pnas.1019502108  0.44
2010 Zuris JA, Halim DA, Conlan AR, Abresch EC, Nechushtai R, Paddock ML, Jennings PA. Engineering the redox potential over a wide range within a new class of FeS proteins. Journal of the American Chemical Society. 132: 13120-2. PMID 20812736 DOI: 10.1021/ja103920k  0.44
2009 Bak DW, Zuris JA, Paddock ML, Jennings PA, Elliott SJ. Redox characterization of the FeS protein MitoNEET and impact of thiazolidinedione drug binding. Biochemistry. 48: 10193-5. PMID 19791753 DOI: 10.1021/bi9016445  0.44
2009 Conlan AR, Axelrod HL, Cohen AE, Abresch EC, Zuris J, Yee D, Nechushtai R, Jennings PA, Paddock ML. Crystal structure of Miner1: The redox-active 2Fe-2S protein causative in Wolfram Syndrome 2. Journal of Molecular Biology. 392: 143-53. PMID 19580816 DOI: 10.1016/j.jmb.2009.06.079  0.44
Show low-probability matches.